127 related articles for article (PubMed ID: 15361180)
1. Histopathologic parameters of prognosis in cervical cancer--a review.
Singh N; Arif S
Int J Gynecol Cancer; 2004; 14(5):741-50. PubMed ID: 15361180
[TBL] [Abstract][Full Text] [Related]
2. Tumor invasion depth is a useful pathologic assessment for predicting outcomes in cervical squamous cell carcinoma after neoadjuvant radiotherapy.
Lv Y; Wang N; Liu Y; Li X; Fan L; Li M; Wang L; Yu Z; Yan Q; Guo Y; Guo S; Wei L; Shi M; Wang Z
Diagn Pathol; 2015 Nov; 10():200. PubMed ID: 26537362
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic factors in uterine cervical and corpus cancer].
Yoshioka T; Inoue Y; Hoshiai H; Noda K
Gan To Kagaku Ryoho; 1995 Sep; 22(10):1417-22. PubMed ID: 7668881
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
5. Development of a New Outcome Prediction Model in Early-stage Squamous Cell Carcinoma of the Oral Cavity Based on Histopathologic Parameters With Multivariate Analysis: The Aditi-Nuzhat Lymph-node Prediction Score (ANLPS) System.
Arora A; Husain N; Bansal A; Neyaz A; Jaiswal R; Jain K; Chaturvedi A; Anand N; Malhotra K; Shukla S
Am J Surg Pathol; 2017 Jul; 41(7):950-960. PubMed ID: 28346327
[TBL] [Abstract][Full Text] [Related]
6. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix.
Gauthier P; Gore I; Shingleton HM; Soong SJ; Orr JW; Hatch KD
Obstet Gynecol; 1985 Oct; 66(4):569-74. PubMed ID: 4047545
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a surgical-pathologic staging and scoring system for cervical cancer.
Li S; Li X; Zhang Y; Zhou H; Tang F; Jia Y; Hu T; Sun H; Yang R; Chen Y; Cheng X; Lv W; Wu L; Zhou J; Wang S; Huang K; Wang L; Yao Y; Yang Q; Yang X; Zhang Q; Han X; Lin Z; Xing H; Qu P; Cai H; Song X; Tian X; Shen J; Xi L; Li K; Deng D; Wang H; Wang C; Wu M; Zhu T; Chen G; Gao Q; Wang S; Hu J; Kong B; Xie X; Ma D
Oncotarget; 2016 Apr; 7(15):21054-63. PubMed ID: 27014971
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the relationship between clinicopathological features and pelvic lymph node metastasis in patients with early stage squamous cell carcinoma of the uterine cervix].
Tian QF; Wang XY; Lü WG; Ye F; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):760-3. PubMed ID: 19087544
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
10. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
Lax SF; Tamussino KF; Lang PF
Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative MR evaluation of features that indicate the need of adjuvant therapies in early stage cervical cancer patients. A single-centre experience.
Rizzo S; Calareso G; Maccagnoni S; Angileri SA; Landoni F; Raimondi S; Pasquali E; Lazzari R; Bellomi M
Eur J Radiol; 2014 May; 83(5):858-64. PubMed ID: 24581810
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of early cervical cancer (FIGO Stages IA2, IB, and IIA) in northern Norway predicted by malignancy grading score and objective morphometric image analysis.
Eggen T; Arnes M; Moe B; Straume B; Orbo A
Int J Gynecol Pathol; 2007 Oct; 26(4):447-56. PubMed ID: 17885497
[TBL] [Abstract][Full Text] [Related]
14. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
15. Pattern of invasion is of prognostic value in surgically treated cervical cancer patients.
Horn LC; Fischer U; Raptis G; Bilek K; Hentschel B; Richter CE; Braumann UD; Einenkel J
Gynecol Oncol; 2006 Dec; 103(3):906-11. PubMed ID: 16876852
[TBL] [Abstract][Full Text] [Related]
16. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
[TBL] [Abstract][Full Text] [Related]
18. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma.
Kristensen GB; Abeler VM; Risberg B; Trop C; Bryne M
Gynecol Oncol; 1999 Aug; 74(2):245-51. PubMed ID: 10419739
[TBL] [Abstract][Full Text] [Related]
19. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma.
Sakuragi N; Takeda N; Hareyama H; Fujimoto T; Todo Y; Okamoto K; Takeda M; Wada Si; Yamamoto R; Fujimoto S
Cancer; 2000 Jun; 88(11):2578-83. PubMed ID: 10861436
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
